BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21097389)

  • 1. Pharmacological and pharmaeconomic considerations.
    Blasi F; Concia E; Mazzei T; Moretti AM; Nicoletti G; Novelli A; Tempera G;
    J Chemother; 2010 Nov; 22 Suppl 1():14-24. PubMed ID: 21097389
    [No Abstract]   [Full Text] [Related]  

  • 2. Etiology issues and problems of antibiotic resistance.
    Blasi F; Concia E; Mazzei T; Moretti AM; Nicoletti G; Novelli A; Tempera G;
    J Chemother; 2010 Nov; 22 Suppl 1():8-13. PubMed ID: 21097388
    [No Abstract]   [Full Text] [Related]  

  • 3. Conclusions. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations.
    Blasi F; Concia E; Mazzei T; Moretti AM; Nicoletti G; Novelli A; Tempera G;
    J Chemother; 2010 Nov; 22 Suppl 1():25-8. PubMed ID: 21097390
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations.
    Blasi F; Concia E; Mazzei T; Moretti AM; Nicoletti G; Novelli A; Tempera G;
    J Chemother; 2010 Nov; 22 Suppl 1():3-4. PubMed ID: 21097386
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic treatment for patients with acute exacerbations of chronic bronchitis.
    Pacios E; Gestoso I; Villarroel P
    Clin Microbiol Infect; 2007 Jul; 13(7):747-8. PubMed ID: 17441978
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use and misuse of antibacterial agents in chronic bronchitis].
    Brubakk O; Walstad RA
    Tidsskr Nor Laegeforen; 2003 May; 123(10):1355-6. PubMed ID: 12806677
    [No Abstract]   [Full Text] [Related]  

  • 7. The place of antibiotic therapy in the management of chronic acute exacerbations of chronic bronchitis.
    Akalin HE
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S49-55. PubMed ID: 11574196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it bacterial or viral? Criteria for distinguishing bacterial and viral infections.
    Benninger M; Segreti J
    J Fam Pract; 2008 Feb; 57(2 Suppl Managing):S5-11. PubMed ID: 18662527
    [No Abstract]   [Full Text] [Related]  

  • 9. Early investigational antibiotics for the treatment of acute exacerbations of chronic bronchitis.
    Falagas ME; Georgiou M
    Expert Opin Investig Drugs; 2017 Mar; 26(3):313-317. PubMed ID: 28092467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic outcomes in the treatment of lower respiratory tract infections.
    Brixner DI
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S400-7. PubMed ID: 15603249
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis].
    Iudina LV; Snezhko VI; Rachko IuV
    Lik Sprava; 2004; (1):34-7. PubMed ID: 17051710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who should receive antibiotics for exacerbations of chronic bronchitis? A plea for more outcome-based studies.
    Niederman MS
    Clin Infect Dis; 2004 Oct; 39(7):987-9. PubMed ID: 15472850
    [No Abstract]   [Full Text] [Related]  

  • 13. Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
    Martinez FJ; Anzueto A
    Am J Med; 2005 Jul; 118 Suppl 7A():39S-44S. PubMed ID: 15993676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute exacerbated bronchitis. New guidelines for choice of antibiotics].
    MMW Fortschr Med; 2001 Nov; 143(48):59. PubMed ID: 11770382
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic bronchitis. When to use antibiotics?].
    MMW Fortschr Med; 2001 Dec; 143(51-52):51. PubMed ID: 11824170
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes in children treated for persistent bacterial bronchitis.
    Byrnes C; Edwards E
    Thorax; 2007 Oct; 62(10):922-3; author reply 923. PubMed ID: 17909192
    [No Abstract]   [Full Text] [Related]  

  • 17. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I; Gogos CA; Bassaris H
    Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbations of chronic bronchitis: new developments concerning microbiology and pathophysiology--impact on approaches to risk stratification and therapy.
    Sethi S; Murphy TF
    Infect Dis Clin North Am; 2004 Dec; 18(4):861-82, ix. PubMed ID: 15555829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
    Kahn JB; Khashab M; Ambruzs M
    Curr Med Res Opin; 2007 Jan; 23(1):1-7. PubMed ID: 17261234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis.
    White AJ; Gompertz S; Bayley DL; Hill SL; O'Brien C; Unsal I; Stockley RA
    Thorax; 2003 Aug; 58(8):680-5. PubMed ID: 12885984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.